Posted by Michael Wonder on 30 Nov 2022

argenx enters into agreement to acquire priority review voucher

argenx

30 November 2022 - argenx today announced an agreement to acquire a US FDA priority review voucher for $102 million.

Read argenx press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Priority review